Veradigm (MDRX) Stock Price, News & Analysis

Company Overview

Veradigm Inc. is a healthcare technology company that develops software, data, and analytics solutions for healthcare providers, payers, and life sciences organizations. Its products are designed to support clinical workflows, electronic health records, practice management, revenue cycle operations, electronic prescribing, and healthcare data exchange.

The company also provides healthcare data and analytics tools intended to help organizations improve clinical decision-making, coordinate care, manage populations, and evaluate treatment and operational outcomes. Veradigm’s platform connects healthcare stakeholders and supports the collection and use of real-world data for research, commercial, and care-management purposes.

Veradigm was formerly known as Allscripts Healthcare Solutions and adopted the Veradigm name in 2023. The company primarily serves the U.S. healthcare market, working with physician practices, health systems, payers, pharmaceutical companies, and other healthcare organizations.

Key Stats

• Today's Range: $4.60 to $5.09
• 50-Day Range: $4.55 to $5.14
• 52-Week Range: $3.25 to $6.00
• Volume: 97,203 shs
• Average Volume: 119,124 shs
• Market Capitalization: $622.51 million
• P/E Ratio: 23.25
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 11/04/2021
• Today: 10/10/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NASDAQ:MDRX
• CIK: 1124804
• Web: veradigm.com
• Phone: (800) 334-8534
• Fax: 313-322-9600
• Employees: 2,300
• Year Founded: 1986

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 23.25
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.53 billion
• Price / Sales: 0.41
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 122,300,000
• Free Float: 105,175,000
• Market Cap: $622.51 million
• Optionable: No Data
• Beta: 0.51